Identification of an optimal prolactin threshold to determine prolactinoma size using receiver operating characteristic analysis

[1]  E. Laws,et al.  Prolactinomas and nonfunctioning adenomas: preoperative diagnosis of tumor type using serum prolactin and tumor size. , 2020, Journal of neurosurgery.

[2]  N. Karavitaki,et al.  Hyperprolactinaemia , 2019, Journal of clinical medicine.

[3]  J. Chambers,et al.  Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: A joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology. , 2019, Clinical endocrinology.

[4]  J. Abucham,et al.  Controversial issues in the management of hyperprolactinemia and prolactinomas – An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism , 2018, Archives of endocrinology and metabolism.

[5]  H. Martin,et al.  Prolactin Biology and Laboratory Measurement: An Update on Physiology and Current Analytical Issues. , 2018, The Clinical biochemist. Reviews.

[6]  S. Aylwin,et al.  Importance of cannulated prolactin test in the definition of hyperprolactinaemia , 2015, Pituitary.

[7]  A. Tirosh,et al.  Hypopituitarism patterns and prevalence among men with macroprolactinomas , 2015, Pituitary.

[8]  S. Cander,et al.  Prolactin levels and gender are associated with tumour behaviour in prolactinomas but Ki-67 index is not. , 2014, Endokrynologia Polska.

[9]  T. Tominaga,et al.  Diagnostic pitfalls of hyperprolactinemia: the importance of sequential pituitary imaging , 2014, BMC Research Notes.

[10]  R. Cámara Gómez,et al.  [Clinical guidelines for diagnosis and treatment of prolactinoma and hyperprolactinemia]. , 2013, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

[11]  A. Colao,et al.  Medical treatment of prolactinomas , 2011, Nature Reviews Endocrinology.

[12]  Victor M Montori,et al.  Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[13]  A. Klibanski,et al.  Clinical practice. Prolactinomas. , 2010, The New England journal of medicine.

[14]  M. Bronstein.  Chapter 7 – Disorders of Prolactin Secretion and Prolactinomas , 2010 .

[15]  M. Gadelha,et al.  Diagnosis and management of hyperprolactinemia: Results of a Brazilian multicenter study with 1234 patients , 2008, Journal of endocrinological investigation.

[16]  H. Nishioka,et al.  Gender-related differences in prolactin secretion in pituitary prolactinomas , 2002, Neuroradiology.

[17]  J. Donckier,et al.  Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. , 1997, The Journal of clinical endocrinology and metabolism.

[18]  G M Besser,et al.  Prolactinomas , 1985, British medical journal.